Pages that link to "Q34745283"
Jump to navigation
Jump to search
The following pages link to Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group (Q34745283):
Displaying 50 items.
- AIDS-Related Malignancies: Emerging Challenges in the Era of Highly Active Antiretroviral Therapy (Q22241462) (← links)
- Therapy Insight: AIDS-related malignancies—the influence of antiviral therapy on pathogenesis and management (Q22251070) (← links)
- Cutaneous manifestations of gastrointestinal disease (Q22252408) (← links)
- Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults (Q24193874) (← links)
- Treatment of Kaposis sarcoma in HIV-1 infected individuals with emphasis on resource poor settings (Q24247970) (← links)
- Clinical Translation of Nanomedicine. (Q30355939) (← links)
- Pegylated liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma (Q30365919) (← links)
- Safety and efficacy of pegylated liposomal doxorubicin in HIV-associated Kaposi's sarcoma. (Q30380999) (← links)
- A risk and benefit assessment of treatment for AIDS-related Kaposi's sarcoma (Q30704009) (← links)
- Phase II study of pegylated liposomal doxorubicin: inactive in recurrent small-cell lung cancer. A Hellenic Cooperative Oncology Group Study (Q31805479) (← links)
- Caelyx (stealth liposomal doxorubicin) in the treatment of advanced breast cancer (Q31884474) (← links)
- Phase II study of carboplatin and liposomal doxorubicin in patients with recurrent squamous cell carcinoma of the cervix (Q33340188) (← links)
- Pegylated liposomal doxorubicin in combination chemotherapy in the treatment of previously untreated aggressive diffuse large-B-cell lymphoma (Q33342531) (← links)
- The systemic treatment of AIDS-related Kaposi's sarcoma (Q33585763) (← links)
- Cardiotoxicity of cancer therapy (Q33704056) (← links)
- Pegylated liposomal adriamycin: a review of current and future applications (Q33798020) (← links)
- Neoplastic complications of HIV infection (Q33814828) (← links)
- New developments in the etiopathogenesis and treatment of HIV-related Kaposi's sarcoma (Q34056503) (← links)
- AIDS oncology (Q34122375) (← links)
- Polyethylene glycol-liposomal doxorubicin: a review of its use in the management of solid and haematological malignancies and AIDS-related Kaposi's sarcoma (Q34150824) (← links)
- Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma (Q34168712) (← links)
- Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy (Q34280875) (← links)
- Clinical aspects and management of AIDS-related Kaposi's sarcoma (Q34292020) (← links)
- Medical management of cutaneous malignancies (Q34322782) (← links)
- Pegylation: a novel process for modifying pharmacokinetics (Q34340198) (← links)
- Kaposi sarcoma-associated herpesvirus-associated malignancies: epidemiology, pathogenesis, and advances in treatment. (Q34470355) (← links)
- AIDS-related tumors: integrating antiviral and anticancer therapy. (Q34552904) (← links)
- Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma: evidence of symptom palliation from chemotherapy (Q34620787) (← links)
- Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 1: epidemiology, environmental predispositions, clinical manifestations, and therapy (Q34683604) (← links)
- Liposomally targeted cytotoxic drugs for the treatment of cancer (Q35051019) (← links)
- Metastatic Kaposi’s Sarcoma with Perirectal Involvement Diagnosed with Endoscopic Ultrasound-Guided EchoBrush Cytology Sampling (Q35149879) (← links)
- Clinical presentations and standard therapy of AIDS-associated Kaposi's sarcoma (Q35174141) (← links)
- Excellent clinical outcomes and retention in care for adults with HIV-associated Kaposi sarcoma treated with systemic chemotherapy and integrated antiretroviral therapy in rural Malawi (Q35668862) (← links)
- Potent antiviral activity of topoisomerase I and II inhibitors against Kaposi's sarcoma-associated herpesvirus (Q35689364) (← links)
- Novel pharmacological therapies for the treatment of AIDS-related Kaposi's sarcoma (Q35779249) (← links)
- Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens (Q35812875) (← links)
- A Prospective Study Assessing Tumour Response, Survival, and Palliative Care Outcomes in Patients with HIV-Related Kaposi's Sarcoma at Queen Elizabeth Central Hospital, Blantyre, Malawi (Q35846173) (← links)
- Therapeutic options for human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus-related disorders (Q35917368) (← links)
- Gastrointestinal Kaposi's sarcoma: Case report and review of the literature (Q35922027) (← links)
- Interactions between antiretrovirals and antineoplastic drug therapy. (Q36012864) (← links)
- Phase II study of bevacizumab in patients with HIV-associated Kaposi's sarcoma receiving antiretroviral therapy (Q36058281) (← links)
- Trends in Kaposi's Sarcoma in Miami Beach from 1987 to 2007 (Q36520006) (← links)
- Pulmonary Kaposi's sarcoma as the initial presentation of human immunodeficiency virus infection (Q36526390) (← links)
- Role of pegylated lyposomal doxorubicin (PLD) in systemic Kaposi's sarcoma: a systematic review (Q36532263) (← links)
- Acquired immunodeficiency syndrome-related malignancies in the era of highly active antiretroviral therapy (Q36546891) (← links)
- Synthesis and biological response of size-specific, monodisperse drug-silica nanoconjugates. (Q36562731) (← links)
- Biodistribution and pharmacokinetics of 111In-DTPA-labelled pegylated liposomes in a human tumour xenograft model: implications for novel targeting strategies (Q36621692) (← links)
- Targeted radiosensitisation by pegylated liposome-encapsulated 3', 5'-O-dipalmitoyl 5-iodo-2'-deoxyuridine in a head and neck cancer xenograft model (Q36695358) (← links)
- Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin (Q36696233) (← links)
- Management of AIDS-related Kaposi's sarcoma (Q36724341) (← links)